Gw&K Investment Management, LLC Intra Cellular Therapies, Inc. Transaction History

Gw&K Investment Management, LLC

$10.8 Billion
Q1 2025

A detailed history of Gw&K Investment Management, LLC transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Gw&K Investment Management, LLC holds 141,109 shares of ITCI stock, worth $18.6 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

141,109

Previous 1,387,462 89.83%

Holding current value

$18.6 Million

Previous $116 Million 83.94%

% of portfolio

0.17%

Previous 0.99%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 05, 2025	SELL	$81.78 - $131.92 $102 Million - $164 Million	-1,246,353 Reduced 89.83%	141,109 $18.6 Million
Q4 2024 Feb 05, 2025	SELL	$71.19 - $91.57 $479,393 - $616,632	-6,734 Reduced 0.48%	1,387,462 $116 Million
Q3 2024 Nov 07, 2024	BUY	$67.99 - $80.84 $14,821 - $17,623	218 Added 0.02%	1,394,196 $102 Million
Q2 2024 Aug 12, 2024	SELL	$64.76 - $79.84 $13.3 Million - $16.4 Million	-204,986 Reduced 12.82%	1,393,978 $95.5 Million
Q1 2024 May 08, 2024	SELL	$64.37 - $75.65 $1.88 Million - $2.22 Million	-29,280 Reduced 1.8%	1,598,964 $111 Million
Q4 2023 Feb 09, 2024	SELL	$46.37 - $73.65 $2.96 Million - $4.7 Million	-63,836 Reduced 3.77%	1,628,244 $117 Million
Q3 2023 Nov 09, 2023	SELL	$52.09 - $64.1 $1.83 Million - $2.26 Million	-35,207 Reduced 2.04%	1,692,080 $88.1 Million
Q2 2023 Aug 09, 2023	SELL	$54.67 - $66.44 $1.41 Million - $1.71 Million	-25,780 Reduced 1.47%	1,727,287 $109 Million
Q1 2023 May 09, 2023	BUY	$43.8 - $56.99 $13.3 Million - $17.3 Million	302,685 Added 20.87%	1,753,067 $94.9 Million
Q4 2022 Feb 10, 2023	SELL	$44.07 - $54.45 $681,013 - $841,415	-15,453 Reduced 1.05%	1,450,382 $76.8 Million
Q3 2022 Nov 09, 2022	BUY	$42.7 - $59.99 $37.7 Million - $52.9 Million	882,242 Added 151.17%	1,465,835 $68.2 Million
Q2 2022 Aug 09, 2022	BUY	$43.0 - $65.64 $1.47 Million - $2.25 Million	34,266 Added 6.24%	583,593 $33.3 Million
Q1 2022 May 09, 2022	BUY	$38.74 - $62.09 $6.82 Million - $10.9 Million	176,007 Added 47.15%	549,327 $33.6 Million
Q4 2021 Feb 11, 2022	BUY	$35.2 - $53.42 $13.1 Million - $19.9 Million	373,320 New	373,320 $19.5 Million

Others Institutions Holding ITCI

# of Institutions

392

Shares Held

92.4M

Call Options Held

2.24M

Put Options Held

1.86M

View Full List

About Intra-Cellular Therapies, Inc.

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $12.4B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

More about ITCI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gw&K Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gw&K Investment Management, LLC with notifications on news.

Account

Gw&K Investment Management, LLC Intra Cellular Therapies, Inc. Transaction History